Companies

Traws Pharma, Inc.

TRAW · CIK 0001130598 · operating

$1.63-1.08%Last updated Mar 2, 8:48 PM

Key Statistics

Valuation

Market Cap$12.95M
P/E
Fwd P/E-0.38
PEG
P/S4.55
P/B2.54
EV/EBITDA-0.41
EV/Rev2.29

Profitability

Gross Margin
Op. Margin-62997.35%
Net Margin-73682.74%
ROE
ROA-667.11%
FCF Margin-13188.50%

Financial Health

Current Ratio2.16
Debt/Equity
Free Cash Flow-$29.81M
Div. Yield

Growth & Other

Revenue Growth0.00%
EPS Growth-3812.22%
Beta1.76
52W High$3.27
52W Low$0.97

About Traws Pharma, Inc.

Traws Pharma, Inc. (TRAW) is a pharmaceutical preparations company incorporated in DE, listed on the Nasdaq. With a market capitalization of $13 million, Traws Pharma, Inc. is a micro-cap company. The stock currently trades at $1.63, down 1.08% today, with a 52-week range of $0.97–$3.75.

Earnings Per Share (Annual · SEC XBRL)

Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.

Fiscal YearEPS DilutedEPS BasicYoY
2024$-35.21$-35.21-3812.2%
2023$-0.90$-0.90+1.1%
2022$-0.91$-0.91+5.2%
2021$-0.96$-0.96
2020
2019
2018
2017
2016
2015
2014
2013

Latest News

Annual Reports (10-K) · 12 filings

Report DateFiledAccession Number
2024-12-312025-03-310001558370-25-004165SEC ↗
2023-12-312024-04-010001558370-24-004525SEC ↗
2022-12-312023-03-300001558370-23-005107SEC ↗
2021-12-312022-03-210001558370-22-004015SEC ↗
2020-12-312021-03-180001104659-21-038452SEC ↗
2019-12-312020-03-270001047469-20-001878SEC ↗
2018-12-312019-04-010001047469-19-001839SEC ↗
2017-12-312018-03-160001047469-18-001777SEC ↗
2016-12-312017-03-290001047469-17-002146SEC ↗
2015-12-312016-03-280001047469-16-011628SEC ↗
2014-12-312015-03-300001047469-15-002952SEC ↗
2013-12-312014-03-200001047469-14-002718SEC ↗